State DE
Clinical Trials in Delaware
Recruiting clinical trials with at least one study location in Delaware. Data updated daily from ClinicalTrials.gov.
Top Conditions in Delaware
Stage IVB Prostate Cancer AJCC v8 (3)Breast Neoplasms (2)Anatomic Stage II Breast Cancer AJCC v8 (2)Asthma (2)Non Small Cell Lung Cancer (2)Castration-Resistant Prostate Carcinoma (2)Bone Cyst (1)Relapsing Multiple Sclerosis (1)Multiple Sclerosis (1)Advanced Lung Non-Squamous Non-Small Cell Carcinoma (1)Metastatic Lung Non-Squamous Non-Small Cell Carcinoma (1)Recurrent Lung Non-Squamous Non-Small Cell Carcinoma (1)
Frequently Asked Questions — Clinical Trials in Delaware
How many clinical trials are currently recruiting in Delaware?
ClinicalMetric currently tracks 50 actively recruiting clinical trials with at least one location in Delaware. The total number of registered studies—including active but not currently enrolling trials—is 50. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Delaware?
Delaware hosts clinical trials across a broad range of medical conditions, including Stage IVB Prostate Cancer AJCC v8, Breast Neoplasms, Anatomic Stage II Breast Cancer AJCC v8, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Delaware serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Delaware?
To join a clinical trial in Delaware, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Delaware maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Delaware
NCT05865301 N/A
Recruiting
Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Ava...
Condition
Lymphoid Leukemia
Enrollment
500 pts
Location
United States
Sponsor
Stanford University
NCT03331198 Phase 1, Phase 2
Recruiting
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Ref...
Condition
Leukemia, Lymphocytic, Chronic, B-Cell
Enrollment
320 pts
Location
United States, Canada
Sponsor
Juno Therapeutics, a Subsidiar
NCT07058077 Phase 2, Phase 3
Recruiting
A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children a...
Condition
Heterozygous Familial Hypercholesterolemia (HeFH)
Enrollment
153 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
NCT06958328 Phase 3
Recruiting
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Condition
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma
Enrollment
356 pts
Location
United States
Sponsor
NRG Oncology
NCT06290401 N/A
Recruiting
A Socio-ecological Approach for Improving Self-management in Adolescents With SC...
Condition
Anemia, Sickle Cell
Enrollment
310 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
NCT06180811 N/A
Recruiting
Evaluating the Effectiveness of a Food is Medicine Community Health Worker Progr...
Condition
Pre-Eclampsia
Enrollment
250 pts
Location
United States
Sponsor
Christiana Care Health Service
NCT04852887 Phase 3
Recruiting
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, O...
Condition
Stage I Breast Cancer
Enrollment
1,670 pts
Location
United States, Canada, Hong Kong
Sponsor
NRG Oncology
NCT05383911 N/A
Recruiting
Empowering Adolescents and Young Adults With Sickle Cell Disease as Partners in ...
Condition
Sickle Cell Disease
Enrollment
68 pts
Location
United States
Sponsor
Nemours Children's Clinic
NCT07431281 Phase 3
Recruiting
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostom...
Condition
Gastric Cancer
Enrollment
2,130 pts
Location
United States, Australia, Austria
Sponsor
AstraZeneca
NCT07028489 N/A
Recruiting
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or...
Condition
Non Small Cell Lung Cancer
Enrollment
130 pts
Location
United States
Sponsor
N-Power Medicine
NCT06632977 Phase 2
Recruiting
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Condition
Castration-Resistant Prostate Carcinoma
Enrollment
474 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT06852222 Phase 3
Recruiting
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants ...
Condition
Leukemia, Myeloid, Acute
Enrollment
600 pts
Location
United States, Australia, Austria
Sponsor
Janssen Research & Development
NCT03907046 Phase 3
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Condition
Intracerebral Hemorrhage
Enrollment
700 pts
Location
United States
Sponsor
Yale University
NCT07228000 N/A
Recruiting
Bundled Cancer Screening and Genetic Services Navigation
Condition
Breast Cancer Screening
Enrollment
820 pts
Location
United States
Sponsor
Georgetown University
NCT06470243 Phase 3
Recruiting
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemothe...
Condition
Castration-Resistant Prostate Carcinoma
Enrollment
528 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT06876714 Phase 3
Recruiting
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People W...
Condition
Anatomic Stage I Breast Cancer AJCC v8
Enrollment
1,524 pts
Location
United States, Puerto Rico
Sponsor
Alliance for Clinical Trials i
NCT07049783 N/A
Recruiting
Examining the Circadian Timing Effects of the Hypotensive Response to Exercise
Condition
Young Adults
Enrollment
30 pts
Location
United States
Sponsor
Freda Patterson
NCT06932263 Phase 2
Recruiting
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults ...
Condition
Asthma
Enrollment
540 pts
Location
United States, Argentina, Brazil
Sponsor
AstraZeneca
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Condition
Stage III Colon Cancer
Enrollment
1,912 pts
Location
United States, Canada, Puerto Rico
Sponsor
NRG Oncology
NCT06500273 Phase 2
Recruiting
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Condition
Large B-cell Lymphoma
Enrollment
250 pts
Location
United States, Canada
Sponsor
Allogene Therapeutics
NCT05987241 Phase 2, Phase 3
Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the ...
Condition
Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
992 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
NCT07070895 N/A
Recruiting
Cough Management Wellness App for Refractory or Unexplained Chronic Cough
Condition
Refractory Chronic Cough
Enrollment
20 pts
Location
United States
Sponsor
Hyfe Inc
NCT05791877 N/A
Recruiting
Non-Invasive Measurement of Pulmonary Dysfunction in Children With Cerebral Pals...
Condition
Cerebral Palsy
Enrollment
250 pts
Location
United States
Sponsor
Nemours Children's Clinic
NCT06401330 Phase 3
Recruiting
A Study Using Risk Factors to Determine Treatment for Children With Favorable Hi...
Condition
Stage I Mixed Cell Type Kidney Wilms Tumor
Enrollment
1,656 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT07060807 Phase 3
Recruiting
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Condition
Breast Neoplasms
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
Page 2 of 2 — 50 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology